Recombinant Human PACT PKR activating

Energize your research with our Recombinant Human PACT PKR Activating. Here are the key features that make this protein a valuable asset for your experiments: Size and Sensitivity: Available in a 100µg size, our recombinant PACT PKR Activating provides you with the material needed for precise and sensitive results in various experimental setups. High Purity: Our protein is produced with a focus on purity, ensuring accurate and reliable data in your studies related to innate immunity and protein kinase activation. Versatile Applications: Ideal for immune response studies, innate immunity research, and other related applications, making it a versatile tool in your lab. Quality Assurance: Rigorous quality control measures guarantee the protein's consistency and reliability, experiment after experiment. Energize the quality of your research with the precision and high sensitivity of Recombinant Human PACT PKR Activating. Make it a crucial part of your experiments today.

Product Name

Recombinant Human PACT PKR activating

Size

50μg, 200μg, 1mg

Species

Human

Host

E.Coli

Expression Region

1-313

Mol. Weight

34.3 kDa

Tags

determined during production processN-terminal His Tag or N-terminal His-IF2DI Tag

Purity

Greater than 95% as determined by SDS-PAGE

Application

Western Blot, ELISA

Formulation

Lyophilized from a 0.2 μm filtered solution in 10 mM Hepes, 500 mM NaCl with 5% trehalose, pH7.4

Reconstitution

Centrifuge the vial prior to opening, reconstitute in sterile distilled water or buffer of interest to concentration of 0.1-1mg/ml by gently pipetting 2-3 times, don't vortex

Storage

The lyophilized protein is stable at -20°C for up to 1 year, the protein solution can be stored at 2-8°C for up to 1 week. For extended storage, it is recommended to further dilute in a buffer containing 0.1% BSA (make sure BSA will NOT interfere with your experiment ) and store in working aliquots at -20°C to -80°C for 6 months.Avoid repeated freeze/thaw cycle.

Alternative Names

DYT16, HSD14, Interferon inducible double stranded RNA dependent protein kinase activator A, interferon-inducible double stranded RNA-dependent activator, Interferon-inducible double stranded RNA-dependent protein kinase activator A, PACT, PKR associated protein X, PKR associating protein X